Xenon Pharmaceuticals Inc (XENE) Price Prediction & ForecastXENEXenon Pharmaceuticals Inc

Alphio's XENE stock price prediction model matches the current Xenon Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $35.08 (-0.73%). The 1-week path is $35.41 (+0.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Xenon Pharmaceuticals is not a good buy right now due to its current price of $33.49 and a very low RSI of 19.222, indicating oversold conditions. The stock has dropped 25% recently due to a pause in patient enrollment for clinical studies, which raises concerns about its near-term growth prospects. Although there are positive analyst ratings with targets as high as $73, the significant recent decline and ongoing financial losses, including a net loss of $110.7 million in Q2 2026, present considerable risks. The main risk is the company's ongoing financial struggles, as evidenced by a forward P/E ratio of 0 and a price-to-sales ratio of 0, indicating no current revenue generation. Therefore, it is advisable to sell or hold off on purchasing until the situation stabilizes.

Xenon Pharmaceuticals Inc (XENE) last closed at $35.34, losing -3.18%. These facts feed the 1-day and 1-week XENE price prediction above.